Anam Rizvi
Appearances
DateMay 18, 2024Glucagon-like peptide-1 receptor agonists (GLP-1RAs), such as semaglutide, have efficacious results for enhancing glycemic control, promoting weight loss, and reducing cardiovascular risk leading to their increased utilization…Presenter
Speakers
Weill Cornell Medical CenterWeill Cornell Medical Center
DateMay 18, 2024MULTICENTER PILOT RANDOMIZED CONTROLLED TRIAL EVALUATING THE EFFICACY OF THE PRIMARY OBESITY SURGERY ENDOLUMINAL (POSE2…Speakers
Mayo Clinic FloridaInstitute of Digestive and Liver Care, SL Raheja HospitalSwedish Medical CenterWake Forest Baptist HealthModerators
VA Medical CenterUniv Hospital of ClevelandEmory University School of Medicine
DateMay 18, 2024RISK FACTORS FOR INADEQUATE BOWEL PREPARATION IN COLONOSCOPY: A COMPREHENSIVE SYSTEMATIC REVIEW AND META-ANALYSIS OF 146 STUDIESModerators
Indiana University School of MedicineAustin Gastroenterology
